Hillsdale Investment Management’s NuVasive, Inc. NUVA Stock Holding History

Hillsdale Investment Management’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-12,500	Closed	-$633K	–	710
2020 Q1	$633K	Buy	+12,500	New	+$838K	0.08%	241
2015 Q1	–	Sell	-150	Closed	-$7K	–	583
2014 Q4	$7K	Hold	150	–	–	﹤0.01%	518
2014 Q3	$5K	Hold	150	–	–	﹤0.01%	525
2014 Q2	$5K	Hold	150	–	–	﹤0.01%	527
2014 Q1	$6K	Hold	150	–	–	﹤0.01%	509
2013 Q4	$5K	Buy	+150	New	+$4.51K	﹤0.01%	519
2013 Q3	–	Sell	-14,600	Closed	-$362K	–	579
2013 Q2	$362K	Buy	+14,600	New	+$319K	0.12%	121

Other funds holding NUVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ACA

Anchor Capital Advisors Boston, Massachusetts $3.56B AUM 21.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Hillsdale Investment Management's NUVA Position: Q2 2020 in Review

Hillsdale Investment Management sold out of NuVasive, Inc. (NUVA) in Q2 2020, closing a stake of 12,500 shares — an estimated $633K sold.

Hillsdale Investment Management first reported a position in NUVA in Q2 2013 and held it in 7 quarters. The position peaked at $633K in Q1 2020. 290 funds tracked by Wall St. Rank hold NUVA as of Q2 2020.

Hillsdale Investment Management reported no remaining NuVasive, Inc. position as of Q2 2020 after selling out during the quarter.
Hillsdale Investment Management sold 12,500 NuVasive, Inc. shares in Q2 2020, an estimated $633K.
Hillsdale Investment Management first reported a position in NuVasive, Inc. in Q2 2013 and held it in 7 quarters.
Hillsdale Investment Management's NuVasive, Inc. position peaked at $633K in Q1 2020.
290 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q2 2020.

Based on Hillsdale Investment Management's 13F filing for Q2 2020, filed 11 Aug 2020.